MONOPHARMA.NS,0P0001RIYV,4000

MONOPHARMA · General/Diversified · NSE

₹41

Current Market Price

Near Fair Value

Fair Value (DCF)

₹38

Margin of Safety

-5.8%

Updated 9h ago

DCF Sensitivity →

YieldIQ Score

40/100

Piotroski F-Score

4/9

Economic Moat

None

Confidence

13%

ROE

—

Debt/Equity

0.00

WACC

11.1%

Market Cap

₹72 Cr

Quality & Valuation

Neutral model outputs — no recommendations.

ROCE

—

Return on capital employed

EV / EBITDA

—

Enterprise multiple

Debt / EBITDA

—

Leverage vs earnings

Interest Coverage

—

EBIT covers interest

Current Ratio

—

Short-term liquidity

Asset Turnover

1.53×

Revenue per ₹ of assets

Revenue CAGR (3Y)

—

3-year revenue growth

Revenue CAGR (5Y)

—

5-year revenue growth

DCF Scenario Analysis

vs CMP ₹40.85

Bear case

₹25.4

MoS -60.8%

Base case

₹38.48

MoS -6.2%

Bull case

₹41.37

MoS +1.3%

Ratio Trends

Historical ratio trends for MONOPHARMA are being prepared. Once ready, this section will show multi-year trajectories of ROE, ROCE, margins, leverage, and valuation multiples.

Historical Financials

Historical financials for MONOPHARMA are being prepared. Check back shortly for a 5-year view of revenue, earnings, cash flow, and balance-sheet trends.

Peer Comparison

Peers not yet ranked for MONOPHARMA. Comparable companies and side-by-side valuation will appear here once the peer set is established.

Dividend History

No dividend events recorded for MONOPHARMA in the last 10 years.

AI Analysis Summary

Model-generated description of metrics. Not investment advice. The stock's current price is 40.85, with a fair value of 38.48, and a margin of safety of -5.8%. The debt-to-equity ratio is 0.00.

Read full AI analysis →

Reverse DCF

Market-implied growth

What FCF growth is priced in →

Risk Analysis

Recent activity

BSE filings + news for MONOPHARMA →

Compare

Run Full Interactive Analysis

Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.

Analyse MONOPHARMANow →

Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.